018454268

Biopharma Excellence by PharmaLex

---

April 15, 2021

Trademark Summary

The trademark application Biopharma Excellence by PharmaLex was filed by PharmaLex GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on May 24, 2021, and it was registered by office on August 30, 2021 without any oppositions.

The application was filed in English (German was selected as the second language).

Change of name and professional address of the trademark registration was recorded on October 17, 2022.

---

Goods And Services

• The mark was filed in class 9 with following description of goods:
  
  1. Software
  2. Automation software
  3. Artificial intelligence apparatus
  4. Information technology apparatus
  5. Computers
  6. Computer programs for data processing
  7. Computer software applications, downloadable
  8. Unified communications software
  9. Assistive software.
• The mark was filed in class 35 with following description of goods:
  
  1. Advertising, management for others, business administration
  2. Business efficiency expert services
  3. Systemization of information into computer databases
  4. Compilation of information into computer databases
  5. Support and advice in the context of drug distribution in retail and wholesale
  6. Providing outsourced office functions services for drug approval, manufacturing, distribution, security and monitoring
  7. Assistance and consultancy in the context of the retailing and wholesaling of medicines
  8. Consultancy services in the fields of controlling and managing information and implementing and managing databases.
• The mark was filed in class 42 with following description of goods:
  
  1. Scientific and technological services and research and design relating thereto
  2. Scientific, technological, medical and pharmaceutical research and development services
  3. Industrial analysis and research services
  4. Research and development of new products for others
  5. Pharmaceutical drug development services
  6. Research and development of pharmaceutical preparations
  7. Research and analysis services
  8. Biological research
  9. Clinical research
  10. Providing medical and scientific research information
  11. Provision of surveys [scientific]
  12. Scientific laboratory services
  13. Medical research laboratory services
  14. Laboratory research services relating to pharmaceuticals
  15. Research and development in the field of biotherapeutics
  16. Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science
  17. Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars, therapeutics
  18. Development of a web application for entering and evaluating informative texts for pharmaceuticals and medical products, in particular instructions for use, package inserts, specialist information and for the provision of various documents
  19. Database services, namely storage of data in computer databases
  20. Conversion of data or documents from physical to electronic media
  21. Testing, inspection or research of pharmaceuticals and medicines
  22. Design, engineering, research, development and testing services
  23. Research in the field of gene therapy
  24. Quality assurance, quality control and quality management consultancy
  25. Research services relating to scientific work
  26. Preparation of scientific analyzes and evaluations
  27. Pharmaceutical product evaluation
  28. Consultancy pertaining to pharmacology
  29. Consultancy relating to research and development in the field of therapeutics
  30. Consultancy relating to laboratory testing
  31. Pharmaceutical products development
  32. Development of pharmaceutical preparations and medicines
  33. Testing of pharmaceuticals
  34. Provision of information and data relating to medical and veterinary research and development
  35. Inspection of pharmaceuticals
  36. Scientific investigations for medical purposes
  37. Conducting early evaluations in the field of new pharmaceuticals
  38. Medical laboratory services
  39. Information technology services for the pharmaceutical and healthcare industries
  40. Scientific evaluation of drug efficacy
  41. Services for assessing the efficiency of pharmaceuticals
  42. Analysis and evaluation of product design
  43. Analysis and evaluation of product development
  44. Quality control testing
  45. Materials testing and evaluation
  46. Product safety testing
  47. Certification [quality control]
  48. Quality testing of products for certification purposes
  49. Support and advice on drug safety and monitoring
  50. Consultancy services for the development and approval process of biological samples or chemical samples for therapeutic and diagnostic purpose
  51. Consultancy services in the field of design, planning, implementation and project management of clinical trials, pharmacovigilance, pharmaceutical and biotechnology product development
  52. Consultancy services in the fields of biotechnology, pharmaceutical research and development, laboratory testing and pharmacogenetics
  53. Laboratory analysis service relating to the diagnosis and treatment of persons.
• The mark was filed in class 44 with following description of goods:
  
  1. Medical and veterinary services
  2. Pharmacy advice
  3. Providing information relating to the preparation and dispensing of medications
  4. Provision of pharmaceutical information
  5. Provision of information relating to medicine
  6. Consultancy and information services provided via the Internet relating to pharmaceutical products
  7. Consultancy and information services relating to pharmaceutical products
  8. Consultancy and information services relating to biopharmaceutical products
  9. Advisory services relating to pharmaceuticals
  10. Medical, diagnostic and pharmaceutical services and advice
  11. Medical and pharmaceutical consultancy
  12. Medical services relating to the diagnosis and treatment of persons
  13. Medical analysis and examinations
  14. Medical treatment services
  15. Medical services
  16. Medical screening
  17. Medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of illnesses
  18. Medical, diagnostic and pharmaceutical services and advice in the field of drug safety
  19. Providing information in the field of pharmacovigilance and adverse event reporting.
• The mark was filed in class 45 with following description of goods:
  
  1. Regulatory compliance auditing
  2. Regulatory compliance consulting services
  3. Regulatory support and advice in the context of drug approval
  4. Submission of documents, reports and records required for drug approval by regulatory authorities (Regulatory compliance auditing)
  5. Consultancy services in the fields of regulatory compliance and oversight
  6. Advisory services relating to regulatory affairs
  7. Regulatory maintenance of marketing authorizations following approval.